2012
DOI: 10.2215/cjn.11051011
|View full text |Cite
|
Sign up to set email alerts
|

Derivation and Validation of a Cytokine-Based Assay to Screen for Acute Rejection in Renal Transplant Recipients

Abstract: SummaryBackground and objectives Acute rejection remains a problem in renal transplantation. This study sought to determine the utility of a noninvasive cytokine assay in screening of acute rejection.Design, setting, participants, & measurements In this observational cross-sectional study, 64 patients from two centers were recruited upon admission for allograft biopsy to investigate acute graft dysfunction. Blood was collected before biopsy and assayed for a panel of 21 cytokines secreted by PBMCs. Patients we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
24
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(25 citation statements)
references
References 31 publications
1
24
0
Order By: Relevance
“…IL-17, IFN-γ and TNF-α) and low immunosuppressive cytokines (e.g. IL-10 and TGF-β1) [28,29,30]. In this study, Rapa-imDC treatment downregulated the amounts of proinflammatory factors in grafts, including IL-6, TNF-α, IFN-γ and IL-17.…”
Section: Discussionmentioning
confidence: 63%
“…IL-17, IFN-γ and TNF-α) and low immunosuppressive cytokines (e.g. IL-10 and TGF-β1) [28,29,30]. In this study, Rapa-imDC treatment downregulated the amounts of proinflammatory factors in grafts, including IL-6, TNF-α, IFN-γ and IL-17.…”
Section: Discussionmentioning
confidence: 63%
“…Moreover, IL-6 levels did not differentiate ACR from AMR. 17 In a study of 21 ACR and 8 AMR patients, urinary protein levels of endothelial protein c receptor differentiated ACR from AMR with an AUC of 0.875. This study, however, did not include patients with ATI.…”
Section: Discussionmentioning
confidence: 99%
“…The multiplex ability of the bead array is attractive to efficiently measure multiple targets simultaneously. These assays have shown promise in detection of adverse post-transplant responses with increased serum IL-6 and FGL2 identified as potentially predictive of acute rejection in in vitro studies (De Serres et al, 2012; Zhao et al, 2013). This approach however has the same drawback as the ELISPOT analysis in that it cannot be used to identify the cytokine-producing cells.…”
Section: Functional Assaysmentioning
confidence: 99%